Skip to content
All Updates
- Potential Risk of Tumour Lysis Syndrome with SorafenibApril 25, 2025
- Safety Alert of Risk of persistent corneal injury and significant visual impairment with Chlorhexidine (cutaneous use)April 25, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY DRUG TESTING LABORATORIES.April 25, 2025
- Expressions of Interest (EOI) for shortlisting of expert members of Central Licensing Board of DRAPApril 24, 2025
- Prequalification Document for Vendors/Firms through EPADS for the Supply of Services for Repair & Maintenance WorkApril 24, 2025
- Decisions of 78th Meeting of the Medical Device BoardApril 23, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED / SPURIOUS DRUGSApril 22, 2025
- DRAP-PSW Gateway: Online application for Pharmaceutical export certificatesApril 21, 2025
- Bidding Document for Appointment of Tax ConsultantApril 21, 2025
- ADVISORY TO THERAPEUTIC GOODS MANUFACTURERS: MEASURES TO PREVENT DEG/EG CONTAMINATION IN ORAL LIQUID PREPARATIONSApril 21, 2025
- MDMC Data List (Local)April 21, 2025
- MDMC Data List (Import)April 21, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY PROVINCIAL DRUG TESTING LABORATORIES.April 11, 2025
- Decisions of the Medical Device Board from 75-85th MeetingsApril 7, 2025
- Amended Drug Pricing Policy 2018April 7, 2025
- Safety Alert of Risk of severe cutaneous adverse reactions with CefotaximeApril 7, 2025
- Safety Alert risk of severe chemical irritation and damage to tissues with
Promethazine hydrochloride injectionApril 7, 2025 - Safety Alert of Risk of Drug-Induced Liver Injury (DILI) and Severe Cutaneous
Adverse Reactions (SCARs) with EzetimibeApril 7, 2025 - Safety Alert of Risk of pathological gambling with AripiprazoleApril 7, 2025
- Recall Alert: Substandard Products Declared by Provincial Drug Testing Laboratories.March 28, 2025
- Recall Alert: Substandard Products Declared by Provincial Drug Testing LaboratoriesMarch 28, 2025
- Pre-Bid Meeting Minutes and Revised Technical SpecificationMarch 28, 2025
- Disposal of Short Shelf Life CasesMarch 27, 2025
- Reports of serious adverse reactions with Ceftriaxone injection due to
unintentional mixing during reconstitution.March 24, 2025 - Safety Alert of Risk of Medication Errors resulting due to inadvertent intrathecal Tranexamic Acid InjectionMarch 20, 2025
- Notice for submission of documents by the shortlisted candidates for the recruitment of vacant positions in DRAPMarch 18, 2025
- Rapid Alert: CONTAMINATED PROPYLENE GLYCOL (BATCH # YFO1210911) PURPOTEDLY MANUFACTURED BY M/S. DONGYING HI-TECH SPRING CHEMICAL INDUSTRY CO LTD, CHINA.March 15, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED / SPURIOUS DRUGSMarch 13, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED / SPURIOUS DRUGSMarch 13, 2025
- Bidding documents for supply of machinery & IT equipmentMarch 13, 2025
- Result Announced (Test Conducted by HEC/ETC)March 12, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY PROVINCIAL DRUG TESTING LABORATORIES.March 12, 2025
- Minutes of 5th Meeting of the Pharmacovigilance Risk Assessment Expert Committee (PRAEC) held on January 2, 2025March 6, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED / SPURIOUS DRUGSMarch 5, 2025
- Recall Alert: SUBSTANDARD PRODUCTS DECLARED BY PROVINCIAL DRUG TESTING LABORATORIES.March 4, 2025
- Recall Alert: Substandard Products Declared By Provincial Drug Testing Laboratories:March 4, 2025
- Rapid Alert: Presence of Unregistered Tramadol Formulations in the MarketFebruary 27, 2025
- Minutes of the 344th Meeting of the Registration Board Held on 31st December, 2024 to 02nd January, 2025February 25, 2025
- Recall Alert: Recall of Substandard Floonix Injection (Batch # Inj-175) Manufactured by M/s Kayans Pharmaceuticals, IslamabadFebruary 25, 2025
- Rapid Alert: CONTAMINATED PROPYLENE GLYCOL (BATCH # A803S96G46) PURPOTEDLY MANUFACTURED BY M/S. DOW CHEMICAL PACIFIC (SINGAPORE) PRIVATE LIMITED.February 25, 2025
- Recall Alert: Voluntary Recall of all Batches of Lacolep Injection 10mg/ml Manufactured by M/s Hilton Pharma, Karachi.February 25, 2025
- Recall Alert: Substandard Products Declared By Provincial Drug Testing Laboratories.February 21, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED/SPURIOUS DRUGSFebruary 20, 2025
- Recall Alert: Voluntary Recall of 36 Batches of Motival Tablets (Reg # 004539) Manufactured by M/s GSK Pakistan Limited, Karachi.February 18, 2025
- Rapid Alert: CRACKDOWN AGAINST FALSIFIED/SPURIOUS DRUGSFebruary 17, 2025
- Request for revision of shelf life criteria for importing innovator product’s sampleFebruary 13, 2025
- Appointment of tax consultantFebruary 13, 2025
- Tender for appointment of external auditorsFebruary 10, 2025
- Recall Alert: Substandard Products Declared By Provincial Drug Testing Laboratories.February 7, 2025
- Rapid Alert: Crackdown Against Falsified ProductsFebruary 7, 2025
